Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1969 1
1972 1
1973 1
1974 1
1975 2
1977 3
1978 1
1981 1
1984 1
1988 1
1992 1
1993 1
1994 1
1996 1
1997 1
1998 1
1999 1
2000 6
2001 1
2003 2
2004 1
2005 4
2006 1
2010 3
2011 4
2012 2
2013 1
2018 1
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Visual Vignette.
Yang AJ, Magill SB. Yang AJ, et al. Endocr Pract. 2020 Oct;26(10):1230. doi: 10.4158/EP-2019-0592. Endocr Pract. 2020. PMID: 33471725 No abstract available.
The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors.
Marchand L, Disse E, Dalle S, Reffet S, Vouillarmet J, Fabien N, Thivolet C, Cugnet-Anceau C. Marchand L, et al. Acta Diabetol. 2019 Dec;56(12):1239-1245. doi: 10.1007/s00592-019-01402-w. Epub 2019 Aug 19. Acta Diabetol. 2019. PMID: 31423559 Review.
In the present mini-review, we aimed to describe different clinical pictures and pathophysiology associated with these forms of diabetes. ...
In the present mini-review, we aimed to describe different clinical pictures and pathophysiology associated with these forms of diabe …
Rethinking leptin and insulin action: therapeutic opportunities for diabetes.
Yildiz BO, Haznedaroglu IC. Yildiz BO, et al. Int J Biochem Cell Biol. 2006;38(5-6):820-30. doi: 10.1016/j.biocel.2005.09.013. Epub 2005 Oct 3. Int J Biochem Cell Biol. 2006. PMID: 16236542 Review.
Leptin is the first adipokine used in the treatment of hypoleptinemic clinical disorders. Although leptin therapy has limited success in common obesity, it has impressive effects in congenital leptin deficiency, lipoatrophic diabetes and syndromes of severe i …
Leptin is the first adipokine used in the treatment of hypoleptinemic clinical disorders. Although leptin therapy has limited success …
Leptin: from animals to humans.
Veniant MM, LeBel CP. Veniant MM, et al. Curr Pharm Des. 2003;9(10):811-8. doi: 10.2174/1381612033455369. Curr Pharm Des. 2003. PMID: 12678880 Review.
Here in a first part, we review preclinical evidence for direct effects on specific tissues (neurons, liver and muscle) and metabolic pathways. In a second part we review clinical evidence for leptin effects. In particular we review the effects of recombinant human leptin …
Here in a first part, we review preclinical evidence for direct effects on specific tissues (neurons, liver and muscle) and metabolic pathwa …
Immunologic insulin resistance.
Davidson JK, DeBra DW. Davidson JK, et al. Diabetes. 1978 Mar;27(3):307-18. doi: 10.2337/diab.27.3.307. Diabetes. 1978. PMID: 640236
Treatment was successful in 34 patients and unsuccessful in one with lipoatrophic diabetes. The mean initial dose of sulfated insulin was 89 U....
Treatment was successful in 34 patients and unsuccessful in one with lipoatrophic diabetes. The mean initial dose of sulfated …
Leptin and diabetes in lipoatrophic mice.
Gavrilova O, Marcus-Samuels B, Leon LR, Vinson C, Reitman ML. Gavrilova O, et al. Nature. 2000 Feb 24;403(6772):850; discussion 850-1. doi: 10.1038/35002663. Nature. 2000. PMID: 10706272 No abstract available.
Lipoatrophic diabetes in an elderly woman: clinical course and serum adipocytokine concentrations.
Iglesias P, Alvarez Fidalgo P, Codoceo R, Díez JJ. Iglesias P, et al. Endocr J. 2004 Jun;51(3):279-86. doi: 10.1507/endocrj.51.279. Endocr J. 2004. PMID: 15256772 Free article.
Pathophysiology of this disorder is characterized by generalized loss of body fat associated with an infrequent form of diabetes mellitus (lipoatrophic diabetes). Main features of this form of diabetes mellitus are the severe insulin resistance and the absence of ke …
Pathophysiology of this disorder is characterized by generalized loss of body fat associated with an infrequent form of diabetes mellitus ( …
Letter: Management of lipoatrophic diabetes.
Upton GV, Corbin A, Mabry CC, Hollingsworth DR. Upton GV, et al. N Engl J Med. 1975 Mar 13;292(11):592. doi: 10.1056/NEJM197503132921115. N Engl J Med. 1975. PMID: 1110678 No abstract available.
Lipoatrophic diabetes.
Hamwi GJ, Kruger FA, Eymontt MJ, Scarpelli DG, Gwinup G, Byron R. Hamwi GJ, et al. Diabetes. 1966 Apr;15(4):262-8. doi: 10.2337/diab.15.4.262. Diabetes. 1966. PMID: 5929541 No abstract available.
45 results